People often assume that medications work the same way for everyone. In reality, responses can vary widely. One person may experience symptom relief, while another may have side effects or little benefit, even when taking the same medication at the same dose.
One reason for this variability is genetics. Differences in certain genes can affect how the body processes medications, including how quickly drugs are broken down or how strongly they act in the body.
Pharmacogenomic testing is a tool that helps healthcare providers better understand these genetic differences and use that information to support more informed medication decisions.
What is pharmacogenomic testing?
Pharmacogenomic testing, sometimes called PGx testing, analyzes certain genes that influence how the body responds to medications. These genes often affect enzymes and proteins involved in drug metabolism, transport, or action at target sites in the body.
Unlike diagnostic genetic tests, pharmacogenomic testing does not diagnose illness or predict future disease. Its purpose is to help clinicians decide which medication to use and at what dose.
Once a medication is taken, the body absorbs it, processes it, and then eliminates it. Enzymes play a key role in this process and many of them are controlled by genes.
Genetic differences can cause some individuals to absorb medications too slowly or too quickly. Slow metabolism may lead to higher drug levels and increased side effects, while faster metabolism may result in medication levels that are too low to be effective.
Pharmacogenomic testing identifies these variations and helps explain why different people respond to the same medication in different ways.
How does a pharmacogenomic test work?
A pharmacogenomic test is a laboratory test that examines how certain genes influence a person’s reaction to a medication. Most tests require a cheek swab or saliva sample. Blood samples are used less often.
Some tests focus on a single gene related to a specific medication, while most test multiple genes. These panel tests are commonly preferred because they provide useful information across many different medications.
Pharmacogenomic test results are typically easy to understand. Many reports use categories or color coding to indicate how a medication is expected to perform. For example, a medication may be marked as safe to use, use with caution, or avoid.
Some tests are marketed directly to consumers, while others are ordered through clinical laboratories. Tests ordered by healthcare providers are more likely to include clinical interpretation and be integrated into the medical record.
Pacific Mind Health partners with GeneSight® Psychotropic and Tempus to provide laboratory testing services. Our providers then discuss the results with patients and work with them to create a treatment program designed around their needs.
How pharmacogenomic testing is used in mental health care
Pharmacogenomic testing is commonly used in psychiatry because medication responses can vary widely from person to person. It is most often considered for conditions such as depression, anxiety disorders, bipolar disorder, and attention-deficit/hyperactivity disorder (ADHD).
Testing may be recommended when a patient has not responded to medications, experienced significant side effects, or undergone several changes in treatments.
In these cases, pharmacogenomic testing can provide additional context to support treatment planning. It’s important to note, however, that testing does not take the place of a clinical evaluation.
Pharmacogenomic results are used alongside clinical information such as symptoms, medical history, and current medications. Providers may use results to guide medication selection, adjust dosing, or avoid medications that may carry higher risks.
Importantly, pharmacogenomic testing does not predict outcomes with certainty. Instead, it offers probabilities that help reduce trial-and-error prescribing and support safer treatment decisions.
Quality, regulation, and limitations
Many pharmacogenomic tests are performed by laboratories that meet regulatory and accreditation standards. However, the scope and quality of tests can vary. Not all tests analyze the same genes, and not all medications have strong genetic evidence.
Research supports pharmacogenomic testing for certain medications and conditions, particularly in psychiatry and cardiology, while evidence is still emerging in other areas.
Pharmacogenomic testing has limitations. Genetics is only one factor influencing medication response. Age, health conditions, drug interactions, and lifestyle factors also play important roles.
Additionally, some genetic findings are less well studied in people from certain ancestral backgrounds, which can affect test accuracy. These limitations highlight the importance of professional interpretation.
Conclusion
Patients considering pharmacogenomic testing are encouraged to discuss their medication history and treatment goals with their healthcare provider. Understanding how results may influence care and help set appropriate expectations.
Frequently asked questions
What do pharmacogenomic test result categories mean?
Result categories often indicate whether a medication is expected to work as prescribed, may require caution, or may carry increased risk based on genetic findings.
Will pharmacogenomic testing eliminate trial and error?
No. Testing can reduce uncertainty but does not replace monitoring and follow-up during treatment.
Do results apply to family members?
Some genetic traits are inherited, but test results are individual and should not be applied to others without proper evaluation.
Will testing need to be repeated?
In most cases, no. Genetic information remains stable, though updated interpretations may become available as research evolves.
Key takeaways
- Pharmacogenomic testing examines how genes affect medication response
- It helps guide medication choice and dosing but does not diagnose disease
- Testing is commonly used in mental health care when treatment response is unclear
- Results must be interpreted alongside clinical judgment
- Pharmacogenomic testing is a supportive tool, not a guarantee of outcomes
Looking for pharmacogenomic testing services near you?
Pacific Mind Health offers pharmacogenomic testing and treats a wide range of mental health conditions. We also offer medication management, therapy, and interventional treatments like transcranial magnetic stimulation (TMS) and ketamine and Spravato (esketamine). Our experienced clinicians provide compassionate, evidence-based care to help you feel better.
